Claim Missing Document
Check
Articles

Found 2 Documents
Search

Overview of the Production Results of All Blood Components at UDD PMI Semarang City in 2020 Rina Puspita
International Journal of Seocology Volume 02, Issue 03 : May-August 2021
Publisher : STIE AAS Surakarta

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.29040/seocology.v2i03.36

Abstract

All components in the blood have their respective duties and functions that support the work of blood in the body. Blood has many important roles, such as supplying oxygen and nutrients to cells and tissues, helping to get rid of waste or metabolic waste substances to protecting the body from infections and foreign substances that can harm health. This study aims to determine the results of the production of all blood components at UDD PMI Semarang City in January - December 2020, so that the production amount of each type of blood component can be seen. This type of research is a quantitative study with a descriptive research design consisting of one variable of the production of blood components at UDD PMI Semarang City. The research sample used a total sampling of 102,635 samples, the data collection method was in the form of medical record data for UDD PMI Semarang City in the form of the production of blood components from January to December 2020. From 102,635 samples, it was found that the production of Whole Blood (WB) was 6197 kolf/year, Packed Red Cell (PRC) as much as 48802 kolf/year, Thrombocyte Concentrate (TC) as much as 40578 kolf/year, Fresh Frozen Plasma (FFP) as much as 3551 kolf/year, Cryoprecipitate/AHF as much as 396 kolf/year, PRC-Leukodepleted as much as 2518 kolf/year years, and PRC-Leukoreduced as much as 593 kolf/year. In a row, the highest production of blood components at UDD PMI Semarang City in 2020 was PRC 48802 colf/year, TC 40578 colf/year, WB 6197 colf/year, FFP 3551 colf/year, PRC-Leukodepleted 2518 kolf/year, PRC-Leukoreduced 593 colf/year, and AHF396 colf/year.
Overview of Hepatitis B Virus Exposure on NAT and CLIA Blood Examination Methods at PMI Semarang City Rina Puspita
International Journal of Seocology Volume 03, Issue 01 : September - December 2021
Publisher : STIE AAS Surakarta

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.29040/seocology.v3i1.37

Abstract

There are 421 blood bank in Indonesia, only 12 blood bank used NAT method to test transfusion transmitted disease. Whereas NAT is a moleculer test is recommended by WHO to detect window period. These study is to describe transfusion transmitted disease using NAT and CLIA method on exposure to Hepatitis B virus in Red Cross Semarang City periode April-December 2019. The result of NAT and CLIA are diviaded to two groups, reactive or non-reactive on exposure of Hepatiti B virus. The method used in this research is a descriptived method which is analyzed with univariat. The variabel was obtained from medical record from Red Cross Semarang city which consist of reactive or nonreactive in NAT and CLIA as much 6.931 population. The samples used in this study are 100 samples, using the purposive sampling technique with predefined criteria. In 100 samples, we found 19 reactive test with NAT methods, 17 reactive test with NAT and CLIA and finally found 64 non reactive with NAT and CLIA. From the population of 6.931, only 36 is reactive with NAT only, or both NAT and CLIA (19 reactive on NAT methods and 17 reactive on NAT and CLIA methods). As the result only 0,5% is reactive, so NAT and CLIA are important test for blood safety requirements.